Global Orthopedic Digit Implants Market -2024-2031

Global Orthopedic Digit Implants Market -2024-2031

Global Orthopedic Digit Implants Market reached US$ YY million in 2023 and is expected to reach US$ YY million by 2031, growing with a CAGR of YY % during the forecast period 2024-2031.

Orthopedic digit implants serve as medical devices employed to either substitute or mend bones in fingers and toes. Their application extends to rectifying deformities, injuries, or defects in digits. These implants can be crafted from diverse materials, encompassing ceramics and plastics, and offer the flexibility of either being permanently affixed or removable. Generally composed of stainless steel and titanium alloys for enhanced strength, orthopedic implants play a crucial role in bone and joint replacement or support.

The inclusion of a plastic coating mimics artificial cartilage. Internal fixation is an orthopedic surgical procedure wherein implants like plates, pins, and screws are strategically placed to reassemble and stabilize broken bone fragments. These implants, whether utilized in small joints like the elbow, knee, ankles and toes or in addressing back pain through spinal fusion with instruments such as bone plates and bone tornadoes, aim to restore function by replacing or reinforcing damaged parts.

Market Dynamics: Drivers and Restraints

Increasing prevalence of orthopedic disorders

The prevalence of orthopedic disorders, such as osteoarthritis, rheumatoid arthritis (RA), and fractures, rises, there is a corresponding increase in the need for interventions to manage and treat these conditions. Orthopedic digit implants play a crucial role in restoring function and relieving pain associated with these disorders. Chronic orthopedic conditions, such as osteoporosis and osteopenia, contribute to the weakening of bones and an increased risk of fractures. Orthopedic digit implants, such as bone screws and plates, are utilized to provide stability and support during the healing process.

Thus, the above factors helps to boost the market growth. For instance, according to World Health Organization 2023, estimated that, in 2019, about 528 million people worldwide were living with osteoarthritis; an increase of 113% since 1990. About 73% of people living with osteoarthritis are older than 55 years, and 60% are female.

Additionally, according to CDC, estimated that, out of every 100,000 people, 71 are diagnosed with RA every year. About 1.5 million Americans have RA. Women are about two to three times more likely to get RA than men. Hormones in both genders may play a role in either preventing or triggering it. Thus, rise of orthopedic disorders helps to accelerates the market growth.

Market Dynamics: Restraint

Concerns about long-term implant durability

Patients may hesitate to undergo orthopedic implant surgeries if they have concerns about the long-term durability of the implants. Fear of potential complications or the need for future revision surgeries may discourage individuals from choosing implant-based interventions. Orthopedic surgeons and healthcare providers may also express reservations about recommending certain implants if there are doubts about their long-term performance. Surgeons may opt for alternative treatments or conservative management to avoid potential complications.

Concerns about the long-term durability of implants can negatively impact the reputation of implant manufacturers. Companies associated with implant failures may face challenges in gaining trust from healthcare professionals and patients, potentially affecting market share. Persistent concerns about the long-term performance of orthopedic implants may attract increased regulatory scrutiny. Regulatory bodies may impose stricter requirements for approval, leading to delays in bringing new implant technologies to the market. Thus, the above factors restrain the market growth.

For more details of the report, Request for sample

Segment Analysis

The global orthopedic digit implants market is segmented based on type, material, end-user and region.

The metatarsal joint implants segment from the type segment accounted for approximately 31.10% of share

Metatarsal joint implants are medical devices designed to address conditions affecting the metatarsophalangeal (MTP) joints, which are the joints connecting the metatarsal bones (long bones of the foot) to the proximal phalanges (toe bones). These implants are used to alleviate pain, improve joint function, and restore mobility in cases where conservative treatments have proven ineffective. The rise of advancements in orthopedic implant technologies have led to the development of more sophisticated and effective metatarsal joint implants.

Improved materials, design, and manufacturing processes contribute to enhanced durability and functionality, helps to boost the segment growth. For instance, in March 2021, Accufix Surgical had received approval from the U.S. Food and Drug Administration (FDA) to distribute its patented Accu-Joint system, a revolutionary new approach intended to enable full restoration of MTP function and motion, with no resecting or weakening of hard bone.

The Accu-Joint is indicated for use in the treatment of patients with degenerative and post-traumatic arthritis in the MTP joint in the presence of good bone stock, along with the following clinical conditions.

Additionally, in February 2024, AddUp, and Anatomic Implants are working together to submit a 510(k) for the world’s first 3D printed toe joint replacement. The Washington, DC, startup is the first medical device startup company to patent and develop a 1st metatarsophalangeal (MTP) joint replacement that nearly perfectly replicates the human anatomy by leveraging titanium 3D printing technology. Thus, above factors helps to boost the segment growth.

Geographical Analysis

North America accounted for approximately 44.42% of the market share in 2022

North American region is expected to have significant market growth, due to rising incidence of osteoarthritis, a rising elderly demographic, and the increasing popularity of non-intrusive surgical procedures. Moreover, the region benefits from a greater number of market players and the continuous introduction of new products, fostering further growth. The increasing elderly population is poised to be a key factor propelling the growth of this market segment.

For instance, according to Population Reference Bureau 2024, estimated that, the number of Americans ages 65 and older is projected to increase from 58 million in 2022 to 82 million by 2050 (a 47% increase), and the 65-and-older age group's share of the total population is projected to rise from 17% to 23%. The U.S population is older today than it has ever been. The older population is becoming more racially and ethnically diverse. Between 2022 and 2050 the share of the older population that identifies as non-Hispanic white is projected to drop from 75% to 60%.

Additionally, North America boasts advanced healthcare infrastructure and access to advance medical technologies. This facilitates the availability of a wide range of orthopedic implant procedures and contributes to the growth of the market. The increasing popularity of minimally invasive surgical procedures in North America has positively impacted the orthopedic implants market. Patients and healthcare providers often prefer these procedures for quicker recovery times and reduced postoperative complications. Thus, above factors boost the region growth.

COVID-19 Impact Analysis

The orthopedic digit implants market experienced a modest impact from the ongoing COVID-19 pandemic. In the initial stages of the outbreak, the market faced significant challenges, primarily due to strict lockdown measures aimed at containing the virus's spread. This led to a notable shortage of orthopedic digit implants, as the focus of healthcare resources shifted towards addressing the urgent needs of COVID-19 patients. Hospitals prioritized coronavirus cases over admissions for individuals with rheumatoid arthritis, orthopedic disorders, and other chronic conditions.

Additionally, the production of certain medical devices came to a halt, and surgical procedures were temporarily suspended. As a precautionary measure to mitigate the risk of COVID-19 transmission, physicians either postponed or canceled semi-urgent and elective cases. However, as vaccination efforts gained momentum and the availability of resources and raw materials improved, the orthopedic digit implants market has gradually regained momentum.

Market Segmentation

By Type
• Metatarsal Joint Implants
• Metacarpal Joint Implants
• Toe Intramedullary Digit Implants
• Scaphoid Bone Digit Implants
• Hemi phalangeal Digit Implants

By Material
• Silicone
• Metal alloys
• Polymer materials

By End-User
• Hospitals
• Specialty Orthopedic Clinic
• Homecare setting
• Others

By Region
• North America
U.S.
Canada
Mexico
• Europe
Germany
UK
France
Italy
Spain
Rest of Europe
• South America
Brazil
Argentina
Rest of South America
• Asia-Pacific
China
India
Japan
South Korea
Rest of Asia-Pacific
• Middle East and Africa

Competitive Landscape

The major global players in the market include Stryker Corporation, Smith & Nephew plc, Zimmer Biomet Holdings, Inc., Johnson & Johnson (DePuy Synthes), OsteoMed, LLC, Signature orthopedic Implants, Acumed LLC, Integra LifeSciences Corporation, Implanet SA, Wright Medical Group N.V among others.

Why Purchase the Report?
• To visualize the global orthopedic digit implants market segmentation based on type, material, end-user and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of orthopedic digit implants market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.

The global orthopedic digit implants market report would provide approximately 69 tables, 58 figures and 187 Pages.

Target Audience 2023
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies